An artificial intelligence-based algorithm enhances the detection of B lines on lung ultrasound images compared with manual ...

A team led by Christian Baumgartner of the Institute of Health Care Engineering at Graz University of Technology (TU Graz) ...

Sports broadcaster Erin Andrews, a cervical cancer survivor, is joining a national movement to promote early cancer screening, a cause that hits close to home. Andrews, a member of the FOX NFL ...

A state-of-the-art laboratory rolled into Cambria County Tuesday. The Thoracic Oncology Mobile Experience is an 18-wheel truck that travels across the country highlighting the latest robotic-assisted ...

ABSTRACT: Lung cancer stands as the preeminent cause of cancer-related mortality globally. Prompt and precise diagnosis, coupled with effective treatment, is imperative to reduce the fatality rates ...

ABSTRACT: Lung cancer stands as the preeminent cause of cancer-related mortality globally. Prompt and precise diagnosis, coupled with effective treatment, is imperative to reduce the fatality rates ...

The FDA granted breakthrough therapy designation to Ifinatamab deruxtecan for some with extensive-stage small cell lung cancer. The U.S. Food and Drug Administration (FDA) has granted Breakthrough ...

Two studies led by Johns Hopkins Kimmel Cancer Center, Ludwig Center, and Johns Hopkins Whiting School of Engineering researchers report on a powerful new method that significantly improves the ...

Tristan Rogers, the actor whose career spanned decades and was marked by his well-known portrayal of Robert Scorpio on ABC's daytime television soap opera "General Hospital," has died. He was 79.

For years now, AI cancer detection has been touted as being as good as or better than doctors — but given the results of a recent trial, for some doctors, AI seems to have greatly hampered their ...

SEVEN NEWS. LUNG CANCER REMAINS THE LEADING CAUSE OF CANCER RELATED DEATH IN THE UNITED STATES. AS MEDICAL EXPERT DOCTOR RAMO EXPLAINS, RECENT GUIDELINE CHANGES COULD HELP SAVE THOUSANDS OF LIVES.

Lung cancer driven by mutated HER2 proteins already has a targeted therapy, the blockbuster product Enhertu from AstraZeneca and Daiichi Sankyo. A Boehringer Ingelheim drug has won FDA approval for ...